Journal: Communications Biology
Article Title: Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
doi: 10.1038/s42003-020-01577-x
Figure Lengend Snippet: Inhibitors were docked with active site of 3CLpro protein. Panel-I: ligand interaction map. Panel-II: interaction of inhibitors specific amino acids of 3CLpro at active site. Panel-III: lipophilic cavity of active site with drugs interacting with specific amino acids. Boceprevir ( a ), partapravir ( b ), tipranavir ( c ), ombitasvir ( d ), ivermectin ( e ), and micafungin ( f ) are arranged in columns for comparison. Drugs are represented in green color with ball and stick model. Arrows indicate the C–H, N–H, and C–O bonds between drugs and with Cys 145 , His 41 , and Glu 166 residues since they are essential for the enzymatic activity of 3CLpro enzyme. However, we also observed the drugs interacting with neighboring amino acid residues.
Article Snippet: SARS-CoV-2 specific 3CLpro assay kits were purchased from BPS Biosciences (CA) and enzymatic assay was carried out as per the manufacturer’s protocol using 96 well plates.
Techniques: Activity Assay